Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/13203
Title: DNA chip platform: a high-throughput genotyping technology for genetic diagnosis and pharmacogenetic profiling
Authors: LU YI
Keywords: beta-thalassemia, childhood ALL, DNA chip, genotyping, polymorphism, pharmacogenetics
Issue Date: 18-Apr-2008
Source: LU YI (2008-04-18). DNA chip platform: a high-throughput genotyping technology for genetic diagnosis and pharmacogenetic profiling. ScholarBank@NUS Repository.
Abstract: Genetic polymorphisms in human genome can not only become the causative factor for a certain inherited disease, but also alter the risk of developing a particular cancer in at risk population, or influence a patient's treatment response in the therapy. Therefore, genotyping assay may help to control such a disease, understand the aetiology of a cancer, and individualize the treatment based on the patient's genetic profile to maximize the therapeutic efficacy. For these purposes, we exploited the advantages of DNA chip technology and developed two chip-based genotyping strategies: the arrayed primer extension (APEX) and single-nucleotide allele-specific primer extension (AsPEX). This thesis will describe our work of using APEX to screen the mutations that may cause beta-thalassemia, and using multiplex AsPEX to detect polymorphisms in eight xenobiotics-metabolizing genes that may have impact on the susceptibility to developing childhood acute lymphoblastic leukemia (ALL) and the risk of relapse in children with ALL.
URI: http://scholarbank.nus.edu.sg/handle/10635/13203
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
LuY.pdf12.71 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

211
checked on Dec 11, 2017

Download(s)

269
checked on Dec 11, 2017

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.